Novartis Set to Acquire Mariana Oncology to Enhance Radioligand Therapy Pipeline

1 min read

Deal includes a number of radioligand therapies targeting solid tumors, such as breast, prostate, and lung cancers.

You May Also Like

More From Author

+ There are no comments

Add yours